Zobrazeno 1 - 4
of 4
pro vyhledávání: '"AA Toorop"'
Autor:
Emm Strijbis, Frederik Barkhof, Joep Killestein, Eme Coerver, N. F. Kalkers, Zle van Kempen, Zygj van Lierop, B Moraal, AA Toorop, Charlotte E. Teunissen, Eaj Willemse
Publikováno v:
Multiple sclerosis journal-experimental, translational and clinical, 7(2). SAGE Publications Inc.
Multiple Sclerosis Journal-Experimental, Translational and Clinical
van Lierop, Z Y G J, Toorop, A A, Coerver, E M E, Willemse, E A J, Strijbis, E M M, Kalkers, N F, Moraal, B, Barkhof, F, Teunissen, C E, Killestein, J & van Kempen, Z L E 2021, ' Ocrelizumab after natalizumab in JC-virus positive relapsing remitting multiple sclerosis patients ', Multiple sclerosis journal-experimental, translational and clinical, vol. 7, no. 2 . https://doi.org/10.1177/20552173211013831
Multiple Sclerosis Journal-Experimental, Translational and Clinical
van Lierop, Z Y G J, Toorop, A A, Coerver, E M E, Willemse, E A J, Strijbis, E M M, Kalkers, N F, Moraal, B, Barkhof, F, Teunissen, C E, Killestein, J & van Kempen, Z L E 2021, ' Ocrelizumab after natalizumab in JC-virus positive relapsing remitting multiple sclerosis patients ', Multiple sclerosis journal-experimental, translational and clinical, vol. 7, no. 2 . https://doi.org/10.1177/20552173211013831
Ocrelizumab is often used as an alternative therapy in natalizumab-treated MS patients at risk for progressive multifocal leukoencephalopathy (PML). Our objective was to assess efficacy and safety of JC-virus positive patients switching (either direc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7ba49e913fd3b71068caa0700ff5d51f
https://doi.org/10.1177/20552173211013831
https://doi.org/10.1177/20552173211013831
Publikováno v:
Gefaesschirurgie; Dec2023, Vol. 28 Issue 8, p551-563, 13p
Autor:
van Lierop, ZYGJ, Toorop, AA, Coerver, EME, Willemse, EAJ, Strijbis, EMM, Kalkers, NF, Moraal, B, Barkhof, F, Teunissen, CE, Killestein, J, van Kempen, ZLE
Publikováno v:
Multiple Sclerosis Journal - Experimental, Translational & Clinical; 6/1/2021, p1-6, 6p
Autor:
Toorop AA; Department of Neurology, MS Center Amsterdam, Amsterdam UMC Location VUMC, Amsterdam, The Netherlands a.toorop@amsterdamumc.nl., van Kempen ZLE; Department of Neurology, MS Center Amsterdam, Amsterdam UMC Location VUMC, Amsterdam, The Netherlands., Steenhuis M; Biologics Laboratory, Department of Immunopathology, Sanquin Diagnostic Services, Amsterdam, The Netherlands., Nielsen J; Department of Neurology, Ommelander Hospital Groningen, Scheemda, The Netherlands., Sinnige LGF; Department of Neurology, Medical Centre Leeuwarden, Leeuwarden, The Netherlands., van Dijk G; Department of Neurology, Canisius Wilhelmina Hospital, Nijmegen, The Netherlands., Roosendaal CM; Department of Neurology, Slingeland Hospital, Doetinchem, The Netherlands., Arnoldus EPJ; Department of Neurology, Elisabeth-TweeSteden Hospital, Tilburg, The Netherlands., Hoitsma E; Department of Neurology, Alrijne Hospital, Leiden, The Netherlands., Lissenberg-Witte BI; Department of Epidemiology and Data Science, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands., de Jong BA; Department of Neurology, MS Center Amsterdam, Amsterdam UMC Location VUMC, Amsterdam, The Netherlands., Oosten BWV; Department of Neurology, MS Center Amsterdam, Amsterdam UMC Location VUMC, Amsterdam, The Netherlands., Strijbis EMM; Department of Neurology, MS Center Amsterdam, Amsterdam UMC Location VUMC, Amsterdam, The Netherlands., Uitdehaag BMJ; Department of Neurology, MS Center Amsterdam, Amsterdam UMC Location VUMC, Amsterdam, The Netherlands., Rispens T; Biologics Laboratory, Department of Immunopathology, Sanquin Diagnostic Services, Amsterdam, The Netherlands.; Landsteiner Laboratory, Amsterdam UMC Location AMC, Amsterdam, The Netherlands., Killestein J; Department of Neurology, MS Center Amsterdam, Amsterdam UMC Location VUMC, Amsterdam, The Netherlands.
Publikováno v:
Journal of neurology, neurosurgery, and psychiatry [J Neurol Neurosurg Psychiatry] 2023 Jun; Vol. 94 (6), pp. 482-486. Date of Electronic Publication: 2023 Jan 13.